SAFIRA­®

Giving Anaesthetists Control

Safer Injection for Regional Anaesthesia

About SAFIRA

SAFIRA®: SAFer Injection for Regional Anaesthesia

  • Creates a single operator procedure
  • Engineered safety solution to control injection pressure threshold
  • Reduces chances of nerve injury
  • Improves patient safety


Current Regional Anaesthesia process:

Current regional anaesthesia procedures require two operators - an anaesthetist who holds an ultrasound scanner and uses this to guide the needle tip placement and a second operator to inject the anaesthetic solution at a required pressure.

It has been reported that anaesthetic solutions are often injected at high pressure.

High pressure can cause damage to nerve fascicles, with serious nerve damage occurring in up to 1% of procedures and transient nerve damage in up to 8% of cases.


A revolutionary new technology for Regional Anaesthesia:

SAFIRA® - SAFer Injection for Regional Anaesthesia - allows a single operator, an anaesthetist or anesthesiologist, to conduct the whole regional block at safer pressures.

SAFIRA® has been developed in line with international quality standards. Medovate is ISO 13485:2016 certified.


Contact Distributors:

Medovate have appointed distributors for this exciting new technology in the United States of America, Australia and New Zealand, and Israel.

Find details of all appointed distributors here.

Distributors for other countries are in the process of being appointed.


Videos about SAFIRA®:

Scroll down to find and watch videos all about the new SAFIRA® technology.

Product Images

SAFIRA® driver and syringe SAFIRA® foot pedal operator SAFIRA­® being used with NYSORA simulator Introducing SAFIRA® SAFIRA® foot pedal operator SAFIRA® Driver Anaesthetist uses SAFIRA® for an ankle block

"During hands on demonstrations of SAFIRA® at events including WAMM 2019, delegates were able to appreciate the ease of use, the engineered safety benefits and the convenience of their ability to retain control as a single operator during the performance of a nerve block."

— Dr Peter Young, Critical Care Consultant, The Queen Elizabeth Hospital King's Lynn NHS Foundation Trust

"Having full control over the injection means that I know exactly when, where and how much local anaesthetic I am putting into the patient. And also, the objective pressure limit which is built into the system, provides me with confidence that I am less likely to cause nerve injury."

— Dr Stewart Southey, Consultant Anaesthetist

"SAFIRA® can easily be integrated into clinical practice. The device is very familiar in terms of it being a modified syringe pump. In terms of usage for doing regional anaesthesia blocks, it is very intuitive and it is easy to understand how to aspirate and how to inject using the device."

— Dr Joseph Carter, Consultant Anaesthetist, York Teaching Hospitals NHS Foundation Trust

""My first impressions of SAFIRA® were the simplicity, the ease of use. New clinicians were able to just pick it up and use it straight away without any difficulty at all.""

— Mr Chris Withey, Consultant Surgeon (Orthopaedics)